These findings suggest a nuanced relationship between BDNF, OSA severity, and CPAP therapy, underscoring the potential role of BDNF in the pathophysiology of severe OSA and its modulation by CPAP intervention. The gene discussed is BDNF; the disease is obstructive sleep apnea syndrome.